Menu
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist that works through the central nervous system, rather than targeting blood vessels like traditional erectile dysfunction medications. This unique mechanism makes it a distinct option in the field of sexual wellness treatments.
Originally derived from Melanotan II, PT-141 has been researched for its effects on sexual desire and arousal pathways in the brain. It has been FDA-approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, and continues to receive interest for off-label use in men experiencing sexual dysfunction or low libido.
Unlike hormone-based therapies, PT-141 is considered a non-hormonal option, making it an alternative for individuals who may not respond well to testosterone therapy, PDE5 inhibitors, or other conventional approaches.
At Hawaii Natural Medicine, PT-141 may be offered as part of a comprehensive sexual wellness consultation, which focuses on identifying underlying contributors to low libido, arousal challenges, or sexual dysfunction.
This treatment option may be considered for patients who:
All treatment decisions are made based on a personalized consultation and clinical evaluation.
Individual results may vary and depend on underlying health factors and clinical evaluation.
